A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway.

NCT05834348 · clinicaltrials.gov ↗

COMPLETED

Status

5279

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG: lorlatinib
DRUG: crizotinib
DRUG: brigatinib
DRUG: ceritinib
DRUG: alectinib
DRUG: atezolizumab
DRUG: bevacizumab
DRUG: paclitaxel
DRUG: carboplatin
DRUG: docetaxel
DRUG: erlotinib
DRUG: gefitinib
DRUG: afatinib
DRUG: dacomitinib
DRUG: osimertinib
DRUG: pembrolizumab
DRUG: nivolumab
DRUG: entrectinib

Sponsor

Pfizer